Hoth Therapeutics Announces Positive Results from First-of-its-Kind Human Patient Treatment of EGFRi-Associated Skin Toxicities with HT-001

Cancer Patient Ceased Treatment After One Week Due to Rapid Success Overview In the reported case, the patient, a 59-year-old female undergoing treatment at George Washington University for metastatic breast cancer, experienced significant improvement in symptoms just one week after initiating HT-001 therapy. Due to the swift resolution of lesions and the alleviation of discomfort,…

Read More

Ridgeline Minerals Discovers High-Grade Copper and Gold at Big Blue Porphyry Project in Nevada

Ridgeline Minerals Corp Expands Big Blue Land Position High-grade Au Rock Chip Sample Reveals Visible Gold in Quartz Vein Induced Polarization Geophysics Survey Complete In a recent announcement, Ridgeline Minerals Corp has revealed that it has expanded its Big Blue land position by 23%, marking a significant milestone for the company. The expansion comes after…

Read More

Breaking News: Medera Inc. to Join NASDAQ via Merger with Keen Vision Acquisition Corporation

Medera: Revolutionizing Cardiovascular Disease Treatment Introduction Medera, a clinical-stage biotechnology company, is at the forefront of targeting difficult-to-treat cardiovascular diseases. Their focus on next-generation gene- and cell-based approaches, in combination with bioengineered human mini-heart drug discovery and screening technology platforms, sets them apart in the field of biotech innovation. Merger and Growth The recent merger…

Read More

Jazz Pharmaceuticals to Showcase Improved Epilepsy Outcomes with Epidiolex/Cannabidiol at European Epilepsy Congress 2024

Jazz Pharmaceuticals Announces Presentation of Data on Epidyolex® Treatment at European Epilepsy Congress DUBLIN, Sept. 5, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will present eight abstracts at the 15th European Epilepsy Congress (EEC), including results of the BECOME Caregiver Survey. The survey focuses on the real-world outcomes of Epidyolex® (cannabidiol) treatment on patients…

Read More

Exciting News: Red Pine’s C$7.0 Million Bought Deal Private Placement of Common Shares, Tranche 1 & 2 Flow-Through Shares Announced!

Feeling the Pulse of Red Pine Exploration Inc.’s Latest Announcement Exciting News from Red Pine Exploration Inc. Recently, Red Pine Exploration Inc. made a significant announcement that has certainly caught the attention of investors and industry analysts alike. The company has entered into an agreement with Haywood Securities Inc. to embark on a “bought deal”…

Read More